Barclays Maintains Equal-Weight on Qiagen, Raises Price Target to $40
QIAGEN NV
QIAGEN NV QGEN | 0.00 |
Barclays analyst Luke Sergott maintains Qiagen (NYSE:
QGEN) with a Equal-Weight and raises the price target from $38 to $40.
Barclays Maintains Equal-Weight on Qiagen, Raises Price Target to $40
QIAGEN NV QGEN | 0.00 |